CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Harbin Pharmaceutical Group Co., Ltd. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Harbin Pharmaceutical Group Co., Ltd.
No.7 Qunli Avenue, Daoli District
Phone: +86 45151870077p:+86 45151870077 HAERBIN, HNG  150070  China Ticker: 600664600664
Business Summary
Harbin Pharmaceutical Group Co is a China-based company mainly engaged in pharmaceutical research and development. The Company's main businesses are innovative research and development in high-tech fields such as antibiotics, modern Chinese medicine, and biopharmaceuticals, covering the business sectors of antibiotics, over-the-counter drugs and health products, traditional and modern Chinese medicine, biomedicine, and pharmaceutical commerce. The Company’s main products include calcium gluconate oral solution, zinc gluconate oral solution, amoxicillin capsules, Shuanghuanglian oral solution, alprostadil injection, pediatric paracetamol Huangnamin granules, lacidipine tablets, hydrochloric acid for injection Cefotiam, ibuprofen granules, Xingaizhonggai high calcium tablets, etc.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
2836 Biological products, except diagnostic substances
8731 Commercial physical and biological research
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board XiaopingHu 54 12/27/2023 1/8/2021
President, Director ChuanyouLu 61 12/27/2023 1/8/2021
Finance Director, Vice President BoLiu 61 12/27/2023 9/26/2008
9 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
GNC Holdings, LLC 300 6th Avenue Pittsburgh PA United States

Business Names
Business Name
600664
GNC Holdings, LLC
Harbin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group Company Ltd
ZT Biopharmaceutical LLC

General Information
Number of Employees: 9,853 (As of 12/31/2023)
Outstanding Shares: 2,521,278,976 (As of 12/31/2023)
Shareholders: 98,299
Stock Exchange: SHA
Fax Number: +86 45151870077


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 26, 2024